Open Nav

Mezzion Pharma

  • Erik Emerson, Mezzion Pharmaceuticals

Introduction of company post Phase 3 enrollment completion

  • Date:Wednesday, October 17
  • Time:10:00 AM - 10:15 AM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:We seek to discover new medicines and use our extensive trial experience to deliver hope to patients in areas where hope is needed.
  • Company -
  • Company HQ City:Chicago, Il and seoul south korea
  • Company HQ Country:Korea - South Korea
  • Market Cap:400,000,000
  • Ticker:KRW
  • Exchange:KOSDAQ
  • CEO/Top Company Official:Dean Park
  • Year Founded:1983
  • Main Therapeutic Focus:Orphan/Rare Diseases
  • Lead Product in Development :udenafil
  • Development Phase of Primary Product:Phase III
Erik Emerson
Mezzion Pharmaceuticals